The following has been posted with the permission of their authors James E. Valentine and James C. Shehan of Hyman, Phelps & McNamara as part of their FDA Law Blog. *** August 09, 2014 FDA’s New Biosimilars Guidance Has Sponsors Provide Information to Win Reference Product Exclusivity; Liberal Criteria Opens the Door to More Exclusivities [...]
The post FDA’s New Biosimilars Guidance appeared first on Biotechnology Patent Law Blog | Patents4Life by Warren Woessner.